About Index Trending news
Lists
Pricing
Aerie Pharmaceuticals

Aerie Pharmaceuticals

Aerie Pharmaceuticals

Aerie Pharmaceuticals is focused on developing products for the pharmaceuticaltreatment of glaucoma.

Elsewhere

Contributors to this profile

Alexa global traffic share

09 Sep 2014
$125,000,000
Post-IPO equity
07 Mar 2011
$41,364,965
Venture capital (Series B)